Data / Form D filings / MARIZYME, INC.
MARIZYME, INC.: Form D filings
MARIZYME, INC., a biotechnology company in Jupiter, FL, filed 7 Form D notices with the SEC between 2011 and 2023. The latest, on May 19, 2023, reports $1 million sold of a $10 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 555 HERITAGE DRIVE, SUITE 205, Jupiter, FL, 33458
- Phone
- (561) 935-9955
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1413754
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2023 | New notice | $10,000,000 | $1,000,000 | $9,000,000 | 1 | May 15, 2023 | sec.gov |
| May 10, 2023 | New notice | $265,216 | $265,216 | 4 | Apr 18, 2023 | sec.gov | |
| Nov 3, 2021 | New notice | $10,000,000 | $1,174,945 | $8,825,055 | 4 | May 27, 2021 | sec.gov |
| Oct 19, 2021 | New notice | $10,000,000 | $1,174,945 | $8,825,055 | 4 | May 27, 2021 | sec.gov |
| Aug 5, 2020 | Amendment | $6,000,000 | $5,562,580 | $437,420 | 22 | Aug 3, 2020 | sec.gov |
| Sep 17, 2018 | New notice | $14,554,903 | $14,554,903 | 9 | Sep 12, 2018 | sec.gov | |
| Mar 30, 2011 | New notice | $7,555,000 | $7,555,000 | 25 | Mar 15, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William Hearl | Director | |
| Michael Stewart | Director | |
| Steven Brooks | Executive Officer | |
| David Barthel | Executive Officer, Director | |
| Vithalbhai Dhaduk | Executive Officer, Director | |
| Nilesh Patel | Director | |
| Catherine Pachuk | Executive Officer | |
| Terry Brostowin | Director | |
| George Kovalyov | Executive Officer | |
| Julie Kampf | Director | |
| Harrison Ross | Executive Officer |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of May 15, 2023 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MARIZYME, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.